| Sandra L Fritsch, MD | |
|
13123 E 16th Ave, Aurora, CO 80045-7106 | |
| (720) 777-1234 | |
| Not Available |
| Full Name | Sandra L Fritsch |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 13123 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154330934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD17192 (Maine) | Secondary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | DR.0056184 (Colorado) | Primary |
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
CONRAD, a leading reproductive health research organization, will announce results of the SILCS Diaphragm contraceptive effectiveness study September 17th at the Reproductive Health 2011 Conference in Las Vegas, Nevada.
SuiteMed Solutions, a NC Triad healthcare technology company, announces it is customizing their SuiteMed EHR to facilitate receipt of patient data from ALR Technologies' patented Health-E-Connect patient monitoring system. This data can be important for care plan evaluation, monitoring services billing and reimbursement as well as lending to the "meaningful use" criteria for government funding to medical clinics for implementation of EHRs.
athenahealth, Inc., a leading provider of internet-based business services to physician practices, today announced that on November 10, 2009, the U.S. Patent and Trademark Office has issued athenahealth a patent entitled, ‘Practice Management and Billing Automation System' (U.S. Patent No. 7,617,116) for its athenaNet® rules engine that is part of the Company's revenue cycle management service, athenaCollectorSM.
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Celtic Pharmaceutical Holdings L.P., the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes®, for the topical treatment of onychomycosis (also known as a fungal nail infection).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra L Fritsch, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Sandra L Fritsch, MD 13123 E 16th Ave, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
CONRAD, a leading reproductive health research organization, will announce results of the SILCS Diaphragm contraceptive effectiveness study September 17th at the Reproductive Health 2011 Conference in Las Vegas, Nevada.
SuiteMed Solutions, a NC Triad healthcare technology company, announces it is customizing their SuiteMed EHR to facilitate receipt of patient data from ALR Technologies' patented Health-E-Connect patient monitoring system. This data can be important for care plan evaluation, monitoring services billing and reimbursement as well as lending to the "meaningful use" criteria for government funding to medical clinics for implementation of EHRs.
athenahealth, Inc., a leading provider of internet-based business services to physician practices, today announced that on November 10, 2009, the U.S. Patent and Trademark Office has issued athenahealth a patent entitled, ‘Practice Management and Billing Automation System' (U.S. Patent No. 7,617,116) for its athenaNet® rules engine that is part of the Company's revenue cycle management service, athenaCollectorSM.
A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders.
Celtic Pharmaceutical Holdings L.P., the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes®, for the topical treatment of onychomycosis (also known as a fungal nail infection).
› Verified 8 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |